however, it is not yet approved for use Boehringer Ingelheim, a biopharmaceutical company headquartered in Ingelheim, Germany, has announced promising results from its Phase 3 SYNCHRONIZE-1 clinical trial testing survodutide
The risk of kidney cancer was 38% higher among patients taking GLP-1 drugs, though larger studies are needed to confirm its significance
This remains preclinical only
There are Cineraria Maritima eye drops, which are eye drops that go into the eye, and Homeopathic Cataract Tissue Salts, which is a liquid that also is administered sublingually
GLP-1 and health: Beyond weight loss in the Ozempic era (SACRAMENTO) This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound
A small number of users report mild appetite reduction